Neil Vasdev Selected Research

PF-04802367

1/2022

PET imaging of glycogen synthase kinase-3 in pancreatic cancer xenograft mouse models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neil Vasdev Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 05/2011
14	Alzheimer Disease (Alzheimer's Disease) 08/2021 - 11/2008
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2017
7	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 05/2008
7	Neuroinflammatory Diseases 10/2021 - 04/2014
5	Breast Neoplasms (Breast Cancer) 03/2015 - 10/2009
4	Inflammation (Inflammations) 01/2022 - 10/2011
4	Gliosis 01/2022 - 01/2019
4	Schizophrenia (Dementia Praecox) 01/2020 - 09/2006
3	Brain Neoplasms (Brain Tumor) 01/2022 - 10/2011
3	Tauopathies 10/2018 - 11/2015
3	Brain Diseases (Brain Disorder) 01/2018 - 01/2013
3	Nervous System Diseases (Neurological Disorders) 03/2017 - 07/2013
3	Disease Progression 01/2016 - 11/2010
3	Dementia (Dementias) 01/2016 - 04/2014
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2021 - 09/2016
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021 - 11/2015
2	Cognitive Dysfunction 01/2021 - 01/2016
2	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 10/2018 - 11/2015
2	Atrophy 10/2018 - 01/2017
2	Parkinson Disease (Parkinson's Disease) 01/2018 - 11/2008
2	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2017
2	Pain (Aches) 01/2016 - 07/2013
2	Dehydration (Water Stress) 03/2012 - 01/2011
1	Carcinogenesis 01/2022
1	Chronic Traumatic Encephalopathy 01/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Circulating Neoplastic Cells 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	Diffuse Intrinsic Pontine Glioma 05/2021
1	Feeding and Eating Disorders (Eating Disorder) 01/2020
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2020
1	Epilepsy (Aura) 01/2020
1	Stroke (Strokes) 01/2020
1	Autistic Disorder (Autism) 01/2020
1	Multiple Sclerosis 01/2020
1	Paralysis (Palsy) 01/2020
1	Hypertensive Crisis 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Primary Progressive Aphasia 10/2018

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2012
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
8	EnzymesIBA 05/2021 - 01/2013
7	Monoamine Oxidase (MAO)IBA 01/2022 - 04/2014
6	Pharmaceutical PreparationsIBA 01/2020 - 05/2008
5	Glycogen Synthase Kinase 3IBA 01/2022 - 01/2018
4	Glycogen Synthase (Synthase I)IBA 01/2022 - 04/2014
4	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2021 - 01/2016
4	EndocannabinoidsIBA 01/2020 - 07/2013
4	Amyloid (Amyloid Fibrils)IBA 10/2018 - 11/2015
4	MetalsIBA 01/2018 - 04/2014
3	RadiopharmaceuticalsIBA 01/2020 - 04/2015
3	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2020 - 07/2013
3	tau Proteins (tau Protein)IBA 03/2017 - 04/2014
2	SL25.1188IBA 01/2022 - 01/2019
2	Celecoxib (Celebrex)FDA Link 01/2022 - 10/2020
2	alantolactoneIBA 04/2021 - 09/2016
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020 - 04/2014
2	DNA-Binding Proteins (DNA Binding Protein)IBA 10/2018 - 11/2015
2	CopperIBA 01/2018 - 09/2015
2	ZincIBA 01/2018 - 09/2015
2	SynucleinsIBA 01/2018 - 11/2015
2	IronIBA 01/2018 - 09/2015
2	IonsIBA 01/2018 - 09/2015
2	Phosphotransferases (Kinase)IBA 01/2017 - 11/2010
2	lorlatinibIBA 01/2017 - 01/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2017 - 11/2015
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 09/2006
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 11/2016 - 01/2016
2	anandamide (arachidonylethanolamide)IBA 01/2016 - 07/2013
2	scyllitol (scyllo-inositol)IBA 10/2011 - 10/2009
1	PF-04802367IBA 01/2022
1	Glial Fibrillary Acidic ProteinIBA 01/2022
1	Selegiline (E250)FDA LinkGeneric 01/2022
1	HydrogelsIBA 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Death Domain ReceptorsIBA 01/2022
1	11C-PS13IBA 10/2021
1	Cyclooxygenase 1IBA 10/2021
1	Ketoprofen (Orudis)FDA LinkGeneric 10/2021
1	Activin Receptors (Activin Receptor)IBA 05/2021
1	dipinacoline glutamateIBA 05/2021
1	verubulinIBA 01/2021
1	Minocycline (Cyclops)FDA LinkGeneric 01/2021
1	Serotonin (5 Hydroxytryptamine)IBA 05/2020
1	Dinoprostone (PGE2)FDA Link 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	DinoprostIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	Phospholipases A2 (Phospholipase A2)IBA 01/2018

Therapy/Procedure

12	Therapeutics 01/2022 - 09/2006
2	Drug Therapy (Chemotherapy) 01/2017 - 09/2016
1	Precision Medicine 10/2020